Drugs / Vaccine Therapy
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03631043 | Dec 2018 → Dec 2025 | smoldering plasma cell myeloma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaccine Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03631043 ↗ |
| Modality | Vaccine | “custom peptide-based vaccine” NCT03631043 ↗ |
| Route | Subcutaneous | “personalized vaccine subcutaneously (SC)” NCT03631043 ↗ |